Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates

The 2013 Ebola epidemic in Central and West Africa heralded the emergence of wide-spread, highly pathogenic viruses. The successful recombinant vector vaccine against Ebola (rVSVΔG-ZEBOV-GP) will limit future outbreaks, but identifying mechanisms of protection is essential to protect the most vulner...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunn, Bronwyn M., McNamara, Ryan P., Wood, Lianna, Taylor, Sabian, Devadhasan, Anush, Guo, Wenyu, Das, Jishnu, Nilsson, Avlant, Shurtleff, Amy, Dubey, Sheri, Eichberg, Michael, Suscovich, Todd J., Saphire, Erica Ollmann, Lauffenburger, Douglas, Coller, Beth-Ann, Simon, Jakub K., Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576837/
https://www.ncbi.nlm.nih.gov/pubmed/37061918
http://dx.doi.org/10.1016/j.celrep.2023.112402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576837/
https://www.ncbi.nlm.nih.gov/pubmed/37061918
http://dx.doi.org/10.1016/j.celrep.2023.112402

Ejemplares similares